Eswatini vs Thailand: HIV/AIDS deaths averted by antiretroviral therapy
Eswatini
10,530 deaths
in 2024
Thailand
10,666 deaths
in 2024
Eswatini rank
24th
Thailand rank
23rd
HIV/AIDS deaths averted by antiretroviral therapy over time
- Eswatini
- Thailand
How they compare
Thailand currently reports 10,666 deaths against 10,530 deaths in Eswatini, a difference of 136 deaths.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Thailand ahead.
Eswatini ranks 24th and Thailand ranks 23rd of 157 countries.
Thailand has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Eswatini | Thailand | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 2.7 deaths | 2.7 deaths | Thailand |
| 2000s | 2,256 deaths | 13,768 deaths | 11,513 deaths | Thailand |
| 2010s | 9,542 deaths | 21,782 deaths | 12,240 deaths | Thailand |
| 2020s | 10,848 deaths | 12,351 deaths | 1,503 deaths | Thailand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Eswatini or Thailand?
- Thailand, at 10,666 deaths against 10,530 deaths in Eswatini as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Eswatini and Thailand?
- 136 deaths, with Thailand ahead.
- How many years of comparable data are there for Eswatini and Thailand?
- 35 years are reported by both, from 1990 to 2024.
- How do Eswatini and Thailand rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Eswatini ranks 24th and Thailand ranks 23rd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.